Clinical Trial Update: Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on a study evaluating sirolimus and cyclosporine for treatment-resistant aplastic anemia, currently in Phase 1/2 with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Sirolimus (Sirolimus)

Snippet

Sponsor: Office of Rare Diseases (ORD) | Conditions: Anemia, Aplastic | Phase 1, Phase 2 | Status: UNKNOWN